A prospective,randomized,single-blind,comparative study of Inslow,palatinose-based liquid formula and Meibalance,standard balanced liquid formula,using viscera fat accumulation as a primary endpoint in adults patients with confirmed diagnosis of obesity and impaired glucose tolerance.
Not Applicable
- Conditions
- Obesity and impaired glucose tolerance
- Registration Number
- JPRN-UMIN000001301
- Lead Sponsor
- Meiji Dairies Corporation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1.Participants recieveing anti-diabetic drug 2.Deep chronic drinker 3.Participants with following complications or with past histry *Exocrine diseases of pancreas: Pancreatitis;Tumor; Hemochromatosis,etc. *Endocrine diseases: Cushings's syndrome;Acromegaly, Pheochromocytoma; Hyperthyroidism,etc. *Hepatic diseases:Chronic hepatitis, Hepatic cirrhosis *Patients with gastrectmy or with chronic gastro-enteral disease 4.Female who is pregnant, in a lactation period, child-bearing potential or wishing to be pregnant. 5.Participants judged to be inadequate by the investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method